Tate & Lyle profits hit by fall in sweetener price

A fall in the price paid for Tate & Lyle's Splenda sweetener has hit the firm's profits

Tate & Lyle has reported a fall in profits as a result of an increasingly competitive sweetener market and a decline in beverage sales.

A strong performance for speciality ingredients and food systems was offset by the impact of a prolonged winter and drop in the price for Splenda sucralose, the boss of Tate & Lyle revealed along with the firm’s financial results for the year ending March 31 2013.

On May 29, Tate & Lyle posted earnings before interest and tax (EBIT) of £349M, down 2% from last year. Adjusted profit before tax was down 2% to £322M and earnings per share were also down 2% to 55.7p.

Speciality food ingredients sales were up 4% at £983M, with adjusted operating profit in line with the previous year at £213M.

Bulk ingredients EBIT declined 5% to £172M, with margins stable at 7.9% despite a 6% decline in sales, attributed to a ‘soft’ beverage season and an “unusually prolonged” winter, by the firm.


Tate & Lyle chief executive Javed Ahmed said the competitive environment for sucralose intensified during the final quarter, driven by an increase in capacity in China and a significant overhang of unsold Chinese sucralose.

As a result, the firm experienced a decline in the price paid by renewed contracts for Splenda sucralose, Ahmed said.

“The delivery of solid profit growth in starch-based speciality ingredients and food systems, along with another year of strong growth in emerging markets, was offset by the impact of the cold spring in the US last year followed by the recent severe and prolonged winter, and an increasingly competitive market for Splenda sucralose,” he claimed.

“While we will continue to face sucralose pricing headwinds in the current year, our strong innovation pipeline, robust balance sheet and continued growth in emerging markets means we are well placed to deliver growth over the longer term.”

The firm announced it would invest £100M over the next two years in speciality food ingredients to expand capacity for existing and new products.

Below its estimate

City analyst Shore Capital said the whole results were in line with its expectations, but the Tate & Lyle’s speciality food ingredients and bulk ingredients divisions were below its estimate.

Its analysts Clive Black and Darren Shirley said they were yet to see visible profit from Tate & Lyle’s previous investments.

“Whilst we recognise the considerable heavy lifting that has taken place in upgrading Tate & Lyle’s infrastructure, capability and culture in recent years, we have yet to see such work transfer into more sustained and importantly visible profit growth,” they said.

“Indeed, we have more recently been downgrading forecasts in both the bulk ingredients and speciality food ingredients divisions. We retain our hold recommendation but expect downward pressure on the shares today.”

Related News

Lodge will leave the company after a transitional period

Tate & Lyle appoints new chief financial officer

Tate& Lyle have delivered below-target results for Q1, but expect to be 'broadly in line' with full year expectations.

Tate & Lyle miss first-quarter profit target

Non-bitter sweetener launched

Tate & Lyle reveals non-bitter stevia

Tate & Lyle first warned of increasing competition in the market for sugar alternatives in February, pointing to a flood of low-cost products sold by Chinese competitors.

Sweetener competition sees Tate & Lyle issue second profit warning

The facility is Tate and Lyle's third

Tate & Lyle opens new Chinese facility

Lower prices for Chinese sucralose led to a big drop in Tate & Lyle's profits - and the first of three profit warnings - a year ago

Tate & Lyle shares take £400m hit after profit warning

Tate & Lyle said it expected to finalise a plan to maximise returns from Splenda by the end of the month.

Ajinomoto denies Splenda buyout rumours

Ahmed: 'Steady flow of new products'

Tate & Lyle faces £125M in costs for restructure

Tate & Lyle has been ordered to pay £18M in damages

Tate & Lyle ordered to pay £18M in damages

Tate & Lyle opens technical servie in Mexico

Tate & Lyle expands role in Latin America

Tate & Lyle zero calorie sweetner Tasteva is used in dairy products

Tate & Lyle to invest £30M in ingredients

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.